Diagnostic prediction of COVID-19 based on clinical and radiological findings in a relatively low COVID-19 prevalence area
- PMID: 33865743
- PMCID: PMC8006199
- DOI: 10.1016/j.resinv.2021.03.002
Diagnostic prediction of COVID-19 based on clinical and radiological findings in a relatively low COVID-19 prevalence area
Abstract
Background: Distinguishing coronavirus disease 2019 (COVID-19) pneumonia from other lung diseases is often difficult, especially in a highly comorbid patient population in a low prevalence region. We aimed to distinguish clinical data and computed tomography (CT) images between COVID-19 and other lung diseases in an advanced care hospital.
Methods: We assessed clinical characteristics, laboratory data, and chest CT images of patients with COVID-19 and non-COVID-19 patients who were suspected of having COVID-19 between February 20 and May 21, 2020, at the University of Tokyo Hospital.
Results: Typical appearance for COVID-19 on CT images were found in 24 of 29 COVID-19 cases and 21 of 168 non-COVID-19 cases, according to the Radiological Society of North America Expert Consensus Statement (for predicting COVID-19, sensitivity 0.828, specificity 0.875, positive predictive value 0.533, negative predictive value 0.967). When we focused on cases with typical CT images, loss of taste or smell, and close contact with COVID-19 patients were exclusive characteristics for the COVID-19 cases. Among laboratory data, high fibrinogen (P < 0.01) and low white blood cell count (P < 0.01) were good predictors for COVID-19 with typical CT images in multivariate analysis.
Conclusions: In a relatively low prevalence region, CT screening has high sensitivity to COVID-19 in patients with suspected symptoms. When chest CT findings are typical for COVID-19, close contact, loss of taste or smell, lower white blood cell count, and higher fibrinogen are good predictors for COVID-19.
Keywords: COVID-19; Fibrinogen; Interstitial lung diseases; Taste disorder; White blood cell count.
Copyright © 2021 The Japanese Respiratory Society. Published by Elsevier B.V. All rights reserved.
Conflict of interest statement
Conflict of Interest The authors declare that they have no conflicts of interest for this study.
Figures



Similar articles
-
A comparison of clinical, laboratory and chest CT findings of laboratory-confirmed and clinically diagnosed COVID-19 patients at first admission.Diagn Interv Radiol. 2021 May;27(3):336-343. doi: 10.5152/dir.2020.20270. Diagn Interv Radiol. 2021. PMID: 32876570 Free PMC article.
-
Thoracic imaging tests for the diagnosis of COVID-19.Cochrane Database Syst Rev. 2020 Nov 26;11:CD013639. doi: 10.1002/14651858.CD013639.pub3. Cochrane Database Syst Rev. 2020. Update in: Cochrane Database Syst Rev. 2021 Mar 16;3:CD013639. doi: 10.1002/14651858.CD013639.pub4. PMID: 33242342 Updated.
-
Thoracic imaging tests for the diagnosis of COVID-19.Cochrane Database Syst Rev. 2020 Sep 30;9:CD013639. doi: 10.1002/14651858.CD013639.pub2. Cochrane Database Syst Rev. 2020. Update in: Cochrane Database Syst Rev. 2020 Nov 26;11:CD013639. doi: 10.1002/14651858.CD013639.pub3. PMID: 32997361 Updated.
-
CT screening for COVID-19 in asymptomatic patients before hospital admission.J Infect Chemother. 2021 Feb;27(2):232-236. doi: 10.1016/j.jiac.2020.09.025. Epub 2020 Sep 29. J Infect Chemother. 2021. PMID: 33172767 Free PMC article.
-
Chest CT Severity Score as an Auxiliary Grading Tool to COVID-19 Pneumonia Imaging Classification: A Tertiary Care Experience in Pakistan.J Coll Physicians Surg Pak. 2021 Jan;31(1):14-20. doi: 10.29271/jcpsp.2021.01.14. J Coll Physicians Surg Pak. 2021. PMID: 33546527
Cited by
-
Taste loss as a distinct symptom of COVID-19: A systematic review and meta-analysis.medRxiv [Preprint]. 2021 Oct 9:2021.10.09.21264771. doi: 10.1101/2021.10.09.21264771. medRxiv. 2021. Update in: Chem Senses. 2022 Jan 1;47:bjac001. doi: 10.1093/chemse/bjac001. PMID: 34671775 Free PMC article. Updated. Preprint.
-
Taste loss as a distinct symptom of COVID-19: a systematic review and meta-analysis.Chem Senses. 2023 Jan 1;48:bjad043. doi: 10.1093/chemse/bjad043. Chem Senses. 2023. PMID: 38100383 Free PMC article.
-
Evaluation of thorax computed tomographic findings in COVID-19 variant cases.Respir Investig. 2022 May;60(3):364-368. doi: 10.1016/j.resinv.2021.11.013. Epub 2022 Jan 4. Respir Investig. 2022. PMID: 35000879 Free PMC article.
-
Fukuchi-Manabe Score for Infection Control Measures During the Very Early COVID-19 Pandemic Period When Access to Reverse Transcription-Polymerase Chain Reaction Testing Was Poor in Japan: A Single-Center Observational Prospective Cohort Study.Cureus. 2024 Feb 23;16(2):e54748. doi: 10.7759/cureus.54748. eCollection 2024 Feb. Cureus. 2024. PMID: 38523950 Free PMC article.
-
Clinical Features of Early Stage COVID-19 in a Primary Care Setting.Front Med (Lausanne). 2021 Nov 23;8:764884. doi: 10.3389/fmed.2021.764884. eCollection 2021. Front Med (Lausanne). 2021. PMID: 34888326 Free PMC article.
References
-
- World Health organization coronavirus disease dashboard, https://www.covid19.who.int [accessed on January 31, 2021].
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical